Neuroscience

Marcus Neuroscience Institute – The Boca Raton Observer

Bringing Innovation And Excellence To The Community

More intricate than the most complex computer, the human brain and nervous system are endless sources of wonder. Every day brings new scientific discoveries, deepening our understanding of how they work and what doctors can do when they dont.

At the forefront of this medical frontier are neurologists Svetlana Faktorovich, M.D.; Sameea Husain Wilson, D.O.; and Pooja S. Patel, M.D. Passionate and dedicated, they are key members of the team at Marcus Neuroscience Institute, which provides comprehensive treatment for conditions affecting the brain, spine and peripheral nervous system.

Whats great is that we all have different subspecialties and we work very closely together, says Dr. Faktorovich, who specializes in neurophysiology. Were constantly consulting with each other on complex cases, which benefits the patients.

Established in 2015, Marcus Neuroscience Institute is an innovative nexus for neurologic and neurosurgical care at Boca Raton Regional Hospital, part of Baptist Health South Florida. Here, experts address conditions from brain tumors to back pain and everything in between. That includes movement disorders, seizures, life-threatening strokes and aneurysms, memory disorders, migraines, spine conditions and diseases such as multiple sclerosis and Alzheimers, to name a few.

Dr. Husain Wilson, the Institutes director of movement disorder neurology, has been gratified to see the Institute expand, propelled by community support.

Im very proud that I was the first woman here and that Marcus Neuroscience Institute has succeeded in attracting two other strong, board-certified women as attending neurologists, she says. Women bring a lot to an organization. We can offer a different perspective.

Diversity among doctors is valuable, agrees Dr. Patel, who serves as director of the Institutes epilepsy monitoring unit.

Sometimes patients prefer a female doctor, she explains. They might feel more comfortable talking about the details of their neurological condition or problem.

All three neurologists are highly accomplished in their subspecialties, embracing innovation to best serve their patients.

Dr. Patel, for instance, has been involved in multiple epilepsy research projects and clinical trials for anti-seizure medications. Dr. Husain Wilson, an authority on Parkinsons Disease, treats a wide range of movement disorders and collaborates with the Institutes functional neurosurgeons to provide deep brain stimulation as a treatment option. Dr. Faktorovich, who specializes in neuromuscular medicine, is an expert at diagnosing and treating complex disorders affecting the peripheral nervous system. Her expertise includes electromyography/nerve conduction testing, skin biopsy for the diagnosis of small fiber neuropathy and the use of botulinum toxin for the treatment of various neurological ailments.

Research is important to all of us, says Dr. Husain Wilson, who has participated in more than 50 clinical trials.

Even as it embodies a warm, community feel, the Institute maintains the cutting edge of an academic research and training facility, especially since its home to the neurological residency program of Florida Atlantic Universitys Charles E. Schmidt College of Medicine.

The residents keep us on our toes, and thats something were grateful for, Dr. Faktorovich says. In order to teach, we have to keep up-to-date on all the latest research and guidelines.

The Institute was established with a lead gift of $25 million from the Marcus Foundation, initiated by Billi and Bernie Marcus, the founder and former CEO of The Home Depot.

The Marcus Foundation has committed an additional $15 million to expand the facility, with the first phase slated for completion in mid-2021.

Beyond a stunning facility and sophisticated technology, the Institute is highly regarded because of its exceptional standard of care.

In addition to this impressive new center, the doctors here are given latitude to address the needs of their patients, Dr. Faktorovich says. Im not rushed to see a certain number of patients each day. I have the time to get to know my patients, both medically and as people.

Dr. Patel is excited about the future of the Institute.

What really attracted me here was the environment the people work very well together. We share ideas, with the common goal of providing patients the best possible care, Dr. Patel says. Our plan is to keep building a wider range of subspecialties so that we can help more people.

Marcus Neuroscience Institute is located at 800Meadows Road, Boca Raton. For more information,call 561-955-4600 or visit brrh.com/mni.

Wonder Women Advertising Section

Here is the original post:
Marcus Neuroscience Institute - The Boca Raton Observer

Neuroscience

Virginia Tech doctoral candidate wins NIH award to fuse immunology and neuroscience research – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Oct 22 2020

Gabriela Carrillo didn't always aspire to be a neuroscientist. It wasn't until she was providing in-home behavioral analysis therapy for children with autism that she was drawn to the lab.

"Science gave the families I worked with a lot of hope," said Carrillo, a graduate student in Virginia Tech's translational biology, medicine, and health (TBMH) program. "Parents appreciated the therapy and saw progress, but they were also encouraged by the idea that one day, in our lifetime, a scientific breakthrough in our understanding of autism might help their child."

Now, just six years after her academic switch from studying architecture and psychology to pursuing a career in neuroscience, Carrillo earned a competitive six-year $445,000 National Institutes of Health grant that will fund her remaining doctoral and postdoctoral training.

Gabriela is a talented and passionate scientist whose creativity and tenacity have laid the foundation for her success at achieving this recognition. As a TBMH graduate student, she explored several sub-disciplines of biomedical science and identified the increasingly important nexus of neuroscience, immunology, and infectious disease to develop her dissertation research project. With an increasing appreciation of the susceptibility of the nervous system to infectious agents and organisms, it is imperative that a new generation of neuroscientists are equally facile with understanding the biology of infectious agents and the immune system's response to those infections. Gabby is perfectly positioned to become a leader in this important area."

Michael Friedlander, executive director of the Fralin Biomedical Research Institute at VTC and vice president for health sciences and technology at Virginia Tech

Carrillo studies the molecules that brain cells use to shape connections and share chemical signals through synapses and how brain circuits are altered by infection. In particular, she examines how Toxoplasma gondii - a common parasite that is estimated to infect roughly one in eight Americans - changes brain cell behavior, gene expression, and circuit function, which may lead to intense seizure disorders and psychiatric disease for some patients.

Carrillo met her mentor, Michael Fox, six years ago. Fox, a professor at the Fralin Biomedical Research Institute, mentored Carrillo when she was a Howard Hughes Medical Institute Scieneering Fellow at Virginia Tech and encouraged her to pursue a career in science. After she completed her bachelor's degree in psychology at Virginia Tech, Fox hired Carrillo as a research associate in his lab, where she studied developmental neurobiology for three years before starting graduate school.

"I am incredibly proud of the hard work, commitment, and productivity that have led Gabby to receive this career-defining award," said Fox, who is also director of the School of Neuroscience in Virginia Tech's College of Science. "Gabby has demonstrated over and over that she has the intelligence, drive, and skills to excel in an independent academic career in biomedical science - this award just reinforces this fact and shows I am not the only one who feels this way. It is one of the many reasons that I am fully committed to her scientific development. Moreover, I know whatever effort and time I commit to her, she will commit an equal amount of time to others, who need the same encouragement and mentorship that she received early in her own academic career. It's one of Gabby's greatest character traits."

Carrillo recently first-authored a study published in GLIA that described how the parasite impacts brain cell function. The study, led by Fox, showed that when the parasite invades neurons, a type of immune cell in the brain, called microglia, do something peculiar: they wrap around neurons, impeding their ability to receive inhibitory signals. Building on that discovery, Carrillo is examining the role of immune molecules during infection. The researchers want to know if these molecules play a role in signaling microglia, spurring the immune cells to remove inhibitory synapses or influence synaptic loss.

"Microglia normally help keep the brain tidy - they eat up pathogens, debris, and dying cells. During development they also eat up extra synapses to help refine and appropriately strengthen certain parts of brain circuits. Yet in certain cases of neurodegenerative disease, we see this same process have pathological consequences, where microglia attack otherwise stable and healthy synaptic connections, altering circuits and leading to adverse symptoms," Carrillo said. "In the case of disease caused by infectious agents, such as Toxoplasma gondii, we don't yet know if this action is protective or pathological. Our hope is that studying these neural-immune interactions through the disease progression will reveal these roles and set the groundwork for future therapeutic development."

Carrillo's doctoral research fuses together neurobiology and immunology, but her long-term goal is to study how infections alter brain circuits in babies. Perinatal infections from viruses, bacteria, and parasites, occurring just before or after birth, can hinder a child's development and have long-term neurological and/or neuropsychiatric consequences.

"When I think about the impact that my research could one day have on children and their families - that's what really motivates me," Carrillo said.

This isn't Carrillo's first significant academic achievement. Earlier this year she was selected to join the Society for Neuroscience's competitive Neuroscience Scholars Program. She was also named a Centers for Disease Control and Prevention James A. Ferguson Emerging Infectious Disease RISE Fellow last year, and earned a competitive Howard Hughes Medical Institute Scieneer Research Fellowship while completing her bachelor's degree.

Carrillo is committed to growing the presence of underrepresented minorities in academia and science. She is a graduate student councilor through the regional Society for Neuroscience chapter, volunteers with Skype a Scientist, and also provides mentorship to underrepresented minorities and women through Virginia Western Community College's Women in STEM Program, and Big Brothers Big Sisters of Southwest Virginia. She serves on the Commission on Graduate and Professional Studies and Policies at Virginia Tech, and also helped establish The Big Event in Roanoke - a day of community-based volunteer service.

"I was raised in a Hispanic community with very little scientific exposure that lacked research dialogue between scientists and the community, and I don't often see people who come from my background working in the professional roles I aspire to hold," Carrillo said. "It's important for me to help trainees from diverse backgrounds achieve their academic goals and pursue research careers so that we can have a wider range of perspectives influencing our research questions to also benefit historically underserved communities."

After completing her doctoral studies - a milestone she anticipates to pass in 2022 - Carrillo aspires to join a world-leading neuroimmunology lab for postdoctoral training, paving the way to one day lead her own research lab focusing on perinatal neuroimmunology.

Read the original post:
Virginia Tech doctoral candidate wins NIH award to fuse immunology and neuroscience research - News-Medical.Net

Neuroscience

Analyzing Impacts Of COVID-19 On Neuroscience Antibody or Research Reagents Market Effects, Aftermath And Forecast To 2026 – PRnews Leader

Overview for Neuroscience Antibody or Research Reagents Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.

Neuroscience Antibody or Research Reagents Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024The study of Neuroscience Antibody or Research Reagents market is a compilation of the market of Neuroscience Antibody or Research Reagents broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Neuroscience Antibody or Research Reagents industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.

Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Neuroscience Antibody or Research Reagents industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.

Download PDF Sample of Neuroscience Antibody or Research Reagents Market report @ https://hongchunresearch.com/request-a-sample/91582

Key players in the global Neuroscience Antibody or Research Reagents market covered in Chapter 4:NEOBIOSCIENCEGenscriptThermo Fisher ScientificWuhan Fine Biotech Co., Ltd.

In Chapter 11 and 13.3, on the basis of types, the Neuroscience Antibody or Research Reagents market from 2015 to 2026 is primarily split into:AntibodyResearch Reagents

In Chapter 12 and 13.4, on the basis of applications, the Neuroscience Antibody or Research Reagents market from 2015 to 2026 covers:Anti-ParkinsonAlzheimerPsychoticEpilepticOthers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

For a global outreach, the Neuroscience Antibody or Research Reagents study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.

Here is a short glance at what the study actually encompasses:Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitionsRevenue, cost price, capacity & utilizations, import/export rates and market shareForecast predictions are generated from analytical data sources and calculated through a series of in-house processes.

However, based on requirements, this report could be customized for specific regions and countries.

Brief about Neuroscience Antibody or Research Reagents Market Report with [emailprotected]https://hongchunresearch.com/report/neuroscience-antibody-or-research-reagents-market-size-2020-91582

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Neuroscience Antibody or Research Reagents Market

Chapter Four: Players Profiles

Chapter Five: Global Neuroscience Antibody or Research Reagents Market Analysis by Regions

Chapter Six: North America Neuroscience Antibody or Research Reagents Market Analysis by Countries

Chapter Seven: Europe Neuroscience Antibody or Research Reagents Market Analysis by Countries

Chapter Eight: Asia-Pacific Neuroscience Antibody or Research Reagents Market Analysis by Countries

Chapter Nine: Middle East and Africa Neuroscience Antibody or Research Reagents Market Analysis by Countries

Chapter Ten: South America Neuroscience Antibody or Research Reagents Market Analysis by Countries

Chapter Eleven: Global Neuroscience Antibody or Research Reagents Market Segment by Types

Chapter Twelve: Global Neuroscience Antibody or Research Reagents Market Segment by Applications12.1 Global Neuroscience Antibody or Research Reagents Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Neuroscience Antibody or Research Reagents Sales and Market Share by Applications (2015-2020)12.1.2 Global Neuroscience Antibody or Research Reagents Revenue and Market Share by Applications (2015-2020)12.2 Anti-Parkinson Sales, Revenue and Growth Rate (2015-2020)12.3 Alzheimer Sales, Revenue and Growth Rate (2015-2020)12.4 Psychotic Sales, Revenue and Growth Rate (2015-2020)12.5 Epileptic Sales, Revenue and Growth Rate (2015-2020)12.6 Others Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Neuroscience Antibody or Research Reagents Market Forecast by Regions (2020-2026) continued

Check [emailprotected] https://hongchunresearch.com/check-discount/91582

List of tablesList of Tables and FiguresTable Global Neuroscience Antibody or Research Reagents Market Size Growth Rate by Type (2020-2026)Figure Global Neuroscience Antibody or Research Reagents Market Share by Type in 2019 & 2026Figure Antibody FeaturesFigure Research Reagents FeaturesTable Global Neuroscience Antibody or Research Reagents Market Size Growth by Application (2020-2026)Figure Global Neuroscience Antibody or Research Reagents Market Share by Application in 2019 & 2026Figure Anti-Parkinson DescriptionFigure Alzheimer DescriptionFigure Psychotic DescriptionFigure Epileptic DescriptionFigure Others DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Neuroscience Antibody or Research Reagents Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Neuroscience Antibody or Research Reagents Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Neuroscience Antibody or Research ReagentsFigure Production Process of Neuroscience Antibody or Research ReagentsFigure Manufacturing Cost Structure of Neuroscience Antibody or Research ReagentsFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table NEOBIOSCIENCE ProfileTable NEOBIOSCIENCE Production, Value, Price, Gross Margin 2015-2020Table Genscript ProfileTable Genscript Production, Value, Price, Gross Margin 2015-2020Table Thermo Fisher Scientific ProfileTable Thermo Fisher Scientific Production, Value, Price, Gross Margin 2015-2020Table Wuhan Fine Biotech Co., Ltd. ProfileTable Wuhan Fine Biotech Co., Ltd. Production, Value, Price, Gross Margin 2015-2020Figure Global Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Global Neuroscience Antibody or Research Reagents Revenue ($) and Growth (2015-2020)Table Global Neuroscience Antibody or Research Reagents Sales by Regions (2015-2020)Table Global Neuroscience Antibody or Research Reagents Sales Market Share by Regions (2015-2020)Table Global Neuroscience Antibody or Research Reagents Revenue ($) by Regions (2015-2020)Table Global Neuroscience Antibody or Research Reagents Revenue Market Share by Regions (2015-2020)Table Global Neuroscience Antibody or Research Reagents Revenue Market Share by Regions in 2015Table Global Neuroscience Antibody or Research Reagents Revenue Market Share by Regions in 2019Figure North America Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Europe Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Asia-Pacific Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Middle East and Africa Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure South America Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure North America Neuroscience Antibody or Research Reagents Revenue ($) and Growth (2015-2020)Table North America Neuroscience Antibody or Research Reagents Sales by Countries (2015-2020)Table North America Neuroscience Antibody or Research Reagents Sales Market Share by Countries (2015-2020)Figure North America Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2015Figure North America Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2019Table North America Neuroscience Antibody or Research Reagents Revenue ($) by Countries (2015-2020)Table North America Neuroscience Antibody or Research Reagents Revenue Market Share by Countries (2015-2020)Figure North America Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2015Figure North America Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2019Figure United States Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Canada Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Mexico Neuroscience Antibody or Research Reagents Sales and Growth (2015-2020)Figure Europe Neuroscience Antibody or Research Reagents Revenue ($) Growth (2015-2020)Table Europe Neuroscience Antibody or Research Reagents Sales by Countries (2015-2020)Table Europe Neuroscience Antibody or Research Reagents Sales Market Share by Countries (2015-2020)Figure Europe Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2015Figure Europe Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2019Table Europe Neuroscience Antibody or Research Reagents Revenue ($) by Countries (2015-2020)Table Europe Neuroscience Antibody or Research Reagents Revenue Market Share by Countries (2015-2020)Figure Europe Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2015Figure Europe Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2019Figure Germany Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure UK Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure France Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Italy Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Spain Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Russia Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Asia-Pacific Neuroscience Antibody or Research Reagents Revenue ($) and Growth (2015-2020)Table Asia-Pacific Neuroscience Antibody or Research Reagents Sales by Countries (2015-2020)Table Asia-Pacific Neuroscience Antibody or Research Reagents Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2015Figure Asia-Pacific Neuroscience Antibody or Research Reagents Sales Market Share by Countries in 2019Table Asia-Pacific Neuroscience Antibody or Research Reagents Revenue ($) by Countries (2015-2020)Table Asia-Pacific Neuroscience Antibody or Research Reagents Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2015Figure Asia-Pacific Neuroscience Antibody or Research Reagents Revenue Market Share by Countries in 2019Figure China Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Japan Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure South Korea Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Australia Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure India Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Southeast Asia Neuroscience Antibody or Research Reagents Sales and Growth Rate (2015-2020)Figure Middle East and Africa Neuroscience Antibody or Research Reagents Revenue ($) and Growth (2015-2020) continued

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

More here:
Analyzing Impacts Of COVID-19 On Neuroscience Antibody or Research Reagents Market Effects, Aftermath And Forecast To 2026 - PRnews Leader

Neuroscience

Covid-19 impact on Neuroscience Antibodies and Assays Market Regional Overview and Development Analysis by 2025| Thermo Fisher, Abcam, Bio-Rad, Merck,…

Global Neuroscience Antibodies and Assays Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Chicago, United States, 2020::The global Neuroscience Antibodies and Assays Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Neuroscience Antibodies and Assays Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Neuroscience Antibodies and Assays Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Neuroscience Antibodies and Assays Market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Neuroscience Antibodies and Assays Market.

Leading players of the global Neuroscience Antibodies and Assays Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Neuroscience Antibodies and Assays Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Neuroscience Antibodies and Assays Market. It also provides useful recommendations for new as well as established players of the global Neuroscience Antibodies and Assays Market.

>>> Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Neuroscience Antibodies and Assays Market:

Neuroscience Antibodies and Assays Market competition by top manufacturers/Key player Profiled:Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens

Segmentation by Product:

ConsumablesInstruments

Segmentation by Application:

Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesHospitals & Diagnostic Centers

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2539712

At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Neuroscience Antibodies and Assays industries have also been greatly affected.

In the past few years, the Neuroscience Antibodies and Assays market experienced a growth of XXX, the global market size of Neuroscience Antibodies and Assays reached XXX million $ in 2020, of what is about XXX million $ in 2015.

From 2015 to 2019, the growth rate of global Neuroscience Antibodies and Assays market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Neuroscience Antibodies and Assays market size in 2020 will be XXX with a growth rate of xxx%. This is xxx percentage points lower than in previous years.

As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Neuroscience Antibodies and Assays market size will reach XXX million $ in 2025, with a CAGR of xxx% between 2020-2025.

Scope of the Report:The all-encompassing research weighs up on various aspects including but not limited to important industry definition, product applications, and product types. The pro-active approach towards analysis of investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume and end-use offers more value to the overall statistics on the Neuroscience Antibodies and Assays Market. All factors that help business owners identify the next leg for growth are presented through self-explanatory resources such as charts, tables, and graphic images.

The insight has been added in the report to provide realistic overview of the industry, consist of Neuroscience Antibodies and Assays manufacturers data, i.e. shipment, price, revenue, gross profit, business distribution, etc., SWOT analysis, consumer preference, recent developments and trends, drivers and restrain factors, company profile, investment opportunity, demand gap analysis, forecast market size value/volume, services and product, Porters Five Models, socioeconomic factors, government regulation in Neuroscience Antibodies and Assays industry. Market players can use the report to peep into the future of the global Neuroscience Antibodies and Assays Market and bring important changes to their operating style and marketing tactics to achieve sustained growth.

Global Neuroscience Antibodies and Assays Market: Drivers and RestraintsThe research report delves into the complex and interconnected nature of the market dynamics that are defined by changing needs and wants. It discusses the drivers influencing the global Neuroscience Antibodies and Assays market along with defining their scope. The report presents an in-depth evaluation of consumption trends, which offers an assessment of the changes it has been through over the years. Analysts have also discussed the evolution of disposable incomes and purchasing powers that have impacted the global Neuroscience Antibodies and Assays market in recent years.

Table of Contents

Report Overview:It includes major players of the global Neuroscience Antibodies and Assays Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Neuroscience Antibodies and Assays Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Neuroscience Antibodies and Assays Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Neuroscience Antibodies and Assays Market by application, it gives a study on the consumption in the global Neuroscience Antibodies and Assays Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Neuroscience Antibodies and Assays Market are profiled in this section. The analysts have provided information about their recent developments in the global Neuroscience Antibodies and Assays Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Neuroscience Antibodies and Assays Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Neuroscience Antibodies and Assays Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Neuroscience Antibodies and Assays Market.

Key Findings: This section gives a quick look at important findings of the research study.

Why Report Hive Research:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

Read more from the original source:
Covid-19 impact on Neuroscience Antibodies and Assays Market Regional Overview and Development Analysis by 2025| Thermo Fisher, Abcam, Bio-Rad, Merck,...

Neuroscience

American Neurological Association’s First-Ever All-Virtual, Interactive Meeting Attracts Record Attendance from 47 Countries With Special Focus on…

Newswise The 145th Annual Meeting of the American Neurological Association, its first-ever virtual, interactive event, was attended by 1,421 members and guests from 46 countries and the U.S.A., a greater number than attended any Meeting in recent years. The five-day program which ran from October 4, 2020 through October 9, 2020, featured 67 sessions, with a strong focus on the ground-breaking science being conducted by the Associations early-career members.

This year, we added four Emerging Scholar sessions and highlighted the work of our junior and early career members with the Derek Denny-Brown Young Neurological Scholars symposium, explained ANA2020 Meeting Chair Conrad Chris Weihl, MD, PhD. These symposia were very well-received and well-attended, reflecting the excitement in the research community for this work.

In addition, the Meeting showcased an extensive number of poster abstract submissions, all of which demonstrated that extraordinary work is taking place at all career levels across all subspecialties, and reaffirming that ANA is committed to fostering and advancing academic neurology and neuroscience, Weihl noted.

The Meeting featured 18 Special Interest Group (SIG) Networking sessions this year, which provided an opportunity for members at all career levels to benefit from an exchange of ideas and exploration of the newest science in their respective fields. Also new this year was a Social Justice Symposium, which took place the day before the official start of the meeting, and featured an in-depth exploration of such topics as the impact of social determinants of health, adverse health outcomes for people of color, and health-care policy. In addition, participants participated in interactive breakout sessions designed to develop actionable steps to address inequity within academic neurology and neuroscience.

Members responded enthusiastically to the virtual, interactive format, commenting on the opportunities for networking that were still core to ANAs strong tradition of fostering relationships within the neuroscience and neurology research and educational communities. As an assistant professor, I look to ANA for opportunities for mentorship and networking that can help advance my career, and I wasnt sure this could be accomplished in a virtual setting, said Elizabeth Silbermann, MD But there were a surprising number of virtual sessions that allowed us to gather and discuss the topics we would be exploring in a live meeting setting. It was a great experience, and I ended the Meeting with a number of professional contacts Im excited to reach out to again.

Following the Annual Meeting, ANA announced the recipients of the Poster Awards, and the Emerging Scholar Awards.

ABOUT THE ANA

The American Neurological Association is a professional society of academic neurologists and neuroscientists devoted to advancing the goals of academic neurology; to training and educating neurologists and other physicians in the neurologic sciences; and to expanding both our understanding of diseases of the nervous system and our ability to treat them.

For more information, visit http://www.myana.org or follow @TheNewANA1 on Twitter, @AmericanNeurologicalAssociation on Facebook, or @ananeurology on Instagram.

###

Read the original post:
American Neurological Association's First-Ever All-Virtual, Interactive Meeting Attracts Record Attendance from 47 Countries With Special Focus on...

Neuroscience

Neuroscience Antibodies and Assays Market Brief Analysis by Top Key Players; Roche, Merck, Abcam, BioLegend – The Think Curiouser

The proposed Neuroscience Antibodies & Assays Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.

The Neuroscience Antibodies & Assays Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality.

Furthermore, the Neuroscience Antibodies & Assays Market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.

Request Sample Pages of this research study at https://www.theinsightpartners.com/sample/TIPBT00002234/

The structure of the Neuroscience Antibodies & Assays Market report can be categorized into following sections:

The Prominent/Emerging Players in the Neuroscience Antibodies & Assays Market Research include:

The Neuroscience Antibodies & Assays Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.

Company Overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Financial Performance:

Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title Financial Performance (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others.

Product Benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic Initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPBT00002234/

The Neuroscience Antibodies & Assays Market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: [emailprotected]

Read the original:
Neuroscience Antibodies and Assays Market Brief Analysis by Top Key Players; Roche, Merck, Abcam, BioLegend - The Think Curiouser

Neuroscience

New Theory Suggests Consciousness Is the Brain’s "Energy Field" – Technology Networks

Electromagnetic energy in the brain enables brain matter to create our consciousness and our ability to be aware and think, according to a new theory developed by Professor Johnjoe McFadden from the University of Surrey.Publishing his theory in the eminent Oxford University Press journal Neuroscience of Consciousness, Professor McFadden posits that consciousness is in fact the brains energy field. This theory could pave the way towards the development of conscious AI, with robots that are aware and have the ability to think becoming a reality.

Early theories on what our consciousness is and how it has been created tended towards the supernatural, suggesting that humans and probably other animals possess an immaterial soul that confers consciousness, thought and free will capabilities that inanimate objects lack. Most scientists today have discarded this view, known as dualism, to embrace a monistic view of a consciousness generated by the brain itself and its network of billions of nerves. By contrast, McFadden proposes a scientific form of dualism based on the difference between matter and energy, rather than matter and soul.

The theory is based on scientific fact: when neurons in the brain and nervous system fire, they not only send the familiar electrical signal down the wire-like nerve fibres, but they also send a pulse of electromagnetic energy into the surrounding tissue. Such energy is usually disregarded, yet it carries the same information as nerve firings, but as an immaterial wave of energy, rather than a flow of atoms in and out of the nerves.

This electromagnetic field is well-known and is routinely detected by brain-scanning techniques such as electroencephalogram (EEG) and magnetoencephalography (MEG) but has previously been dismissed as irrelevant to brain function. Instead, McFadden proposes that the brains information- rich electromagnetic field is in fact itself the seat of consciousness, driving free will and voluntary actions. This new theory also accounts for why, despite their immense complexity and ultra-fast operation, todays computers have not exhibited the slightest spark of consciousness; however, with the right technical development, robots that are aware and can think for themselves could become a reality.

Johnjoe McFadden, Professor of Molecular Genetics and Director of the Quantum Biology Doctoral Training Centre at the University of Surrey, said: How brain matter becomes aware and manages to think is a mystery that has been pondered by philosophers, theologians, mystics and ordinary people for millennia. I believe this mystery has now been solved, and that consciousness is the experience of nerves plugging into the brains self-generated electromagnetic field to drive what we call free will and our voluntary actions.

Reference: McFadden J. Integrating information in the brains EM field: the cemi field theory of consciousness. Neurosci Conscious. 2020;2020(1). doi:10.1093/nc/niaa016

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

See the rest here:
New Theory Suggests Consciousness Is the Brain's "Energy Field" - Technology Networks

Neuroscience

What Lies Between Grey and White in the Brain – Technology Networks

Traditionally, neuroscience regards the brain as being made up of two basic tissue types. Billions of neurons make up the grey matter, forming a thin layer on the brains surface. These neuronal cells are interlinked in a mindboggling network by hundreds of millions of white matter connections, running in bundles, deeper in the brain. Until very recently, not much was known about the interface between the white and grey matter the so-called superficial white matter because methods were lacking to study it in living human brains. Yet, previous investigations had suggested the region to be implicated in devastating conditions such as Alzheimers disease and autism. Now a multidisciplinary team led by Nikolaus Weiskopf from the Max Planck Institute for Human Cognitive and Brain Sciences has succeeded in making the superficial white matter visible in the living human brain.

"We demonstrated that the superficial white matter contains a lot of iron. It is known that iron is necessary for the process of myelination," explains Evgeniya Kirilina, first author of the study published in Science Advances. Myelin is what makes the white matter white. Its the fatty coating of nerve cell axons that speeds up transmission of information through the brain. The myelination process can occur throughout the lifespan but is predominant during development. In fact, the largest concentration of iron the researchers found was in the superficial white matter in regions of the frontal cortex, which happens to be the slowest developing structure in the human brain. Incredibly, the human frontal cortex is not fully myelinated until the forth decade of life.

The key to the new method is MRI (Magnetic Resonance Imaging) but at very high field strength. While typical clinical MRI scanners work at 1.5 or 3 Tesla, in terms of the strength of the magnetic field, the Max Planck Institute for Human Cognitive and Brain Sciences houses a powerful 7 Tesla scanner. This, in combination with advanced biophysical model, allowed the team to create very high resolution maps of the white-grey matter border across the entire living brain. The accuracy of their submillimetre maps was assessed against classic and advanced histological methods involving physical dissection and analysis of post mortem brains.

The new method promises many further insights into the organisation of the interface between white and grey matter. Evgeniya Kirilina adds, We hope the method can be used to increase our understanding of brain development as well as pathological conditions involving the superficial white matter.

Reference: Kirilina E, Helbling S, Morawski M, et al.Superficial white matter imaging: Contrast mechanisms and whole-brain in vivo mapping.Sci. Adv. 2020;6(41). doi:10.1126/sciadv.aaz9281

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

The rest is here:
What Lies Between Grey and White in the Brain - Technology Networks

Genetics

Help Me Understand Genetics: MedlinePlus Genetics

Genetics Home Reference has merged with MedlinePlus. Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. Learn more

The resources on this site should not be used as a substitute for professional medical care or advice. Users with questions about a personal health condition should consult with a qualified healthcare professional.

View post:
Help Me Understand Genetics: MedlinePlus Genetics

Immunology

Journal of Allergy and Clinical Immunology Publishes Results from BioCryst’s APeX-2 Pivotal Trial of Oral, Once-Daily Berotralstat for the Prevention…

Berotralstat significantly reduced HAE attack rates versus placebo over 24 weeks

RESEARCH TRIANGLE PARK, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data from the first 24 weeks of the APeX-2 trial of oral, once-daily berotralstat in patients with hereditary angioedema (HAE) have been published online by the Journal of Allergy and Clinical Immunology (JACI).

APeX-2 was a Phase 3, double-blind, placebo-controlled, parallel-group trial that evaluated the efficacy and safety of oral, once-daily berotralstat versus placebo over 24-weeks in 121 HAE patients ages 12 years or older. In the trial, after 24 weeks, both the 110-mg and 150-mg doses of berotralstat significantly reduced HAE attack rates compared with placebo and were safe and well tolerated, with greater attack rate reductions observed for the 150-mg dose.

As the authors concluded, the combination of efficacy, safety, and tolerability with convenient oral, once-daily dosing will make berotralstat an important addition to the HAE-C1-INH therapeutic armamentarium, if approved.

The data from APeX-2 show that berotralstat may provide an important oral option for patients with HAE that could allow them to prevent HAE attacks and reduce their overall burden of therapy, said Bruce Zuraw, M.D., professor of medicine and chief of the Division of Rheumatology, Allergy and Immunology at the University of California School of Medicine, and principal investigator of the APeX-2 trial.

We are excited to have our results published in JACI, building on the compelling pivotal and longer-term data presented at scientific congresses in the past year. HAE patients are waiting for an oral, once-daily option to control their disease. As the authors have recognized, providing patients with an effective, oral therapy is a major step towards the goal of enabling them to live a normal life, said Jon Stonehouse, president and chief executive officer of BioCryst.

Additional details can be found in the manuscript, which is available online at http://www.jacionline.org/inpress. JACI is an official journal of the American Academy of Allergy, Asthma, and Immunology.

The U.S. Food and Drug Administration (FDA) is reviewing a new drug application (NDA) for ORLADEYO (berotralstat) and has set an action date of December 3, 2020, under the Prescription Drug User Fee Act (PDUFA).

In Japan, ORLADEYO is being reviewed under Sakigake designation. The Pharmaceutical and Medical Devices Agency (PMDA) has confirmed their regulatory review schedule and the company expects an approval decision in December 2020.

On March 30, 2020, the company announced that the European Medicines Agency (EMA) had validated its marketing authorization application (MAA) submission for ORLADEYO and begun its formal review of the MAA under the centralized procedure. The company expects an opinion from the Committee for Medicinal Products for Human Use (CHMP) within approximately 12 months from MAA validation.

About BioCryst PharmaceuticalsBioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. BioCryst has several ongoing development programs including ORLADEYO (berotralstat), an oral treatment for hereditary angioedema, BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, galidesivir, a potential treatment for COVID-19, Marburg virus disease and Yellow Fever, and BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva. RAPIVAB (peramivir injection), a viral neuraminidase inhibitor for the treatment of influenza, is BioCryst's first approved product and has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan, Korea and the European Union. Post-marketing commitments for RAPIVAB are ongoing. For more information, please visit the Company's website at http://www.BioCryst.com.

Forward-Looking StatementsThis press release contains forward-looking statements, including statements regarding future results, performance or achievements.These statements are identified by use of terms such as will, expect, may, could, and similar words, although some forward-looking statements may be expressed differently.These statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.Some of the factors that could affect the forward-looking statements contained herein include: the ongoing COVID-19 pandemic, whichcould create challenges in all aspects ofBioCrystsbusiness, including without limitation delays, stoppages, difficulties and increased expenses with respect toBioCrystsanditspartners development, regulatory processes and supply chains, negatively impactBioCrystsability to access the capital or credit markets to financeitsoperations, or have the effect of heightening many of the risks described below or in the documentsBioCrystfilesperiodically with the Securities and Exchange Commission; developingand commercializingORLADEYOorany HAE product candidate may take longer or may be more expensive than planned; BioCryst may not be able to enroll the required number of subjects in planned clinical trials of product candidates; BioCryst may not advance human clinical trials with product candidates as expected; the FDA, EMA, PMDA or other applicable regulatory agency may require additional studies beyond the studies planned for product candidates, may not provide regulatory clearances which may result in delay of planned clinical trials,may impose certain restrictions, warnings, or other requirements on product candidates,may impose a clinical hold with respect to such product candidates, ormaywithhold market approval for product candidates;product candidates, if approved, may not achieve market acceptance; BioCrysts ability to successfully commercialize its product candidates, manage its growth, and compete effectively; and risks related to the international expansion of BioCrysts business.Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCrysts most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, all of which identify important factors that could cause the actual results to differ materially from those contained in BioCrysts forward-looking statements.

BCRXW

Contact:

John Bluth+1 919 859 7910jbluth@biocryst.com

Read the original post:
Journal of Allergy and Clinical Immunology Publishes Results from BioCryst's APeX-2 Pivotal Trial of Oral, Once-Daily Berotralstat for the Prevention...